Trials / Completed
CompletedNCT02176382
Denosumab and Teriparatide Study (DATA-HD and DATA-EX)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to assess the effect of an antiresorptive medication in combination with standard dose or alternate dose teriparatide. The study extension will evaluate the effect of one-dose of zoledronic acid after the teriparatide/denosumab combination.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | denosumab | denosumab subcutaneous injection |
| DRUG | teriparatide | teriparatide daily subcutaneous injection |
| DRUG | Zoledronic acid | zoledronic acid infusion |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2020-02-01
- Completion
- 2020-02-01
- First posted
- 2014-06-27
- Last updated
- 2021-02-09
- Results posted
- 2021-01-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02176382. Inclusion in this directory is not an endorsement.